The European Lead Factory: A Blueprint for Public–Private Partnerships in Early Drug Discovery

por Karawajczyk, Anna, Orrling, Kristina M., de Vlieger, Jon S. B., Rijnders, Ton, Tzalis, Dimitrios
Publicado 2017

Editorial: Public-Private Partnerships as Drivers of Innovation in Healthcare

por de Vrueh, Remco L. A., de Vlieger, Jon S. B., Crommelin, Daan J. A.
Publicado 2019

Identification of the Biotransformation Products of 2-Ethylhexyl 4-(N,N-Dimethylamino)benzoate

por León, Zacarias, de Vlieger, Jon, Chisvert, Alberto, Salvador, Amparo, Lingeman, Henk, Irth, Hubertus, Giera, Martin
Publicado 2009

A pragmatic regulatory approach for complex generics through the U.S. FDA 505(j) or 505(b)(2) approval pathways

por Klein, Kevin, Borchard, Gerrit, Shah, Vinod P., Flühmann, Beat, McNeil, Scott E., de Vlieger, Jon S. B.
Publicado 2021

Development of an online p38α mitogen-activated protein kinase binding assay and integration of LC–HR-MS

por Falck, David, de Vlieger, Jon S. B., Niessen, Wilfried M. A., Kool, Jeroen, Honing, Maarten, Giera, Martin, Irth, Hubertus
Publicado 2010

On-line electrochemistry–bioaffinity screening with parallel HR-LC-MS for the generation and characterization of modified p38α kinase inhibitors

por Falck, David, de Vlieger, Jon S. B., Giera, Martin, Honing, Maarten, Irth, Hubertus, Niessen, Wilfried M. A., Kool, Jeroen
Publicado 2012

Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: “Drug Products, Including Biological Products, that Contain Nanomaterials”

por de Vlieger, Jon S. B., Crommelin, Daan J. A., Tyner, Katherine, Drummond, Daryl C., Jiang, Wenlei, McNeil, Scott E., Neervannan, Sesha, Crist, Rachael M., Shah, Vinod P.
Publicado 2019